Philip W. Majerus

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Acetylation of prostaglandin synthase by aspirin.

G J Roth, N Stanford, Philip W. Majerus · Proceedings of the National Academy of Sciences · 1975 · 1K citations · Full text

Oocyte, Molecular Pharmacology, Acetyl Salicylic Acid +13

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.

G J Roth, Philip W. Majerus · Journal of Clinical Investigation · 1975 · 858 citations · Full text

Platelet Protein, Particulate Fraction Protein, Thrombosis +17

Diglyceride lipase: a pathway for arachidonate release from human platelets.

Randy L. Bell, Donald A. Kennerly, N Stanford et al. · Proceedings of the National Academy of Sciences · 1979 · 691 citations · Full text

Thrombopoiesis, Thrombosis, Arachidonate Release +14

The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.

Jacqueline E. Damen, L Liu, Patricia M. Rosten et al. · Proceedings of the National Academy of Sciences · 1996 · 635 citations · Full text

Unique Protein, Immunology, Molecular Biology +17